Use of CBL exon 8 and 9 mutations in diagnosis of myeloproliferative neoplasms and myelodysplastic/myeloproliferative disorders: an analysis of 636 cases

We analyzed 636 patients with diverse myeloproliferative neoplasms or myelodysplastic/myeloproliferative neoplasms for mutations of the Casitas B-cell lymphoma gene (CBLmut) in exons 8 and 9 and performed correlations to other genetic alterations. CBLmut were detected in 63 of 636 (9.9%) of these se...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Schnittger, Susanne (VerfasserIn) , Reiter, Andreas (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 2012-12-01
In: Haematologica, the hematology journal
Year: 2012, Jahrgang: 97, Heft: 12, Pages: 1890-1894
ISSN:1592-8721
DOI:10.3324/haematol.2012.065375
Online-Zugang:Verlag, Volltext: http://dx.doi.org/10.3324/haematol.2012.065375
Verlag, Volltext: http://www.haematologica.org/content/97/12/1890
Volltext
Verfasserangaben:by Susanne Schnittger, Ulrike Bacher, Tamara Alpermann, Andreas Reiter, Madlen Ulke, Frank Dicker, Christiane Eder, Alexander Kohlmann, Vera Grossmann, Andreas Kowarsch, Wolfgang Kern, Claudia Haferlach, and Torsten Haferlach

MARC

LEADER 00000caa a2200000 c 4500
001 1581112297
003 DE-627
005 20220815013616.0
007 cr uuu---uuuuu
008 180919s2012 xx |||||o 00| ||eng c
024 7 |a 10.3324/haematol.2012.065375  |2 doi 
035 |a (DE-627)1581112297 
035 |a (DE-576)511112297 
035 |a (DE-599)BSZ511112297 
035 |a (OCoLC)1341018855 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Schnittger, Susanne  |d 1961-  |e VerfasserIn  |0 (DE-588)172361834  |0 (DE-627)697305740  |0 (DE-576)133226980  |4 aut 
245 1 0 |a Use of CBL exon 8 and 9 mutations in diagnosis of myeloproliferative neoplasms and myelodysplastic/myeloproliferative disorders  |b an analysis of 636 cases  |c by Susanne Schnittger, Ulrike Bacher, Tamara Alpermann, Andreas Reiter, Madlen Ulke, Frank Dicker, Christiane Eder, Alexander Kohlmann, Vera Grossmann, Andreas Kowarsch, Wolfgang Kern, Claudia Haferlach, and Torsten Haferlach 
246 3 3 |a Use of CBL exon eight and nine mutations in diagnosis of myeloproliferative neoplasms and myelodysplastic/myeloproliferative disorders 
264 1 |c 2012-12-01 
300 |a 5 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 19.09.2018 
520 |a We analyzed 636 patients with diverse myeloproliferative neoplasms or myelodysplastic/myeloproliferative neoplasms for mutations of the Casitas B-cell lymphoma gene (CBLmut) in exons 8 and 9 and performed correlations to other genetic alterations. CBLmut were detected in 63 of 636 (9.9%) of these selected patients. CBLmut were more frequent in myelodysplastic/myeloproliferative neoplasms than myeloproliferative neoplasms (51 of 328, 15.5% vs. 12 of 291, 4.1%; P<0.001). Frequency was 48 of 278 (17.3%) in chronic myelomonocytic leukemia and 3 of 33 (9.1%) in unclassifiable myelodysplastic/myeloproliferative neoplasms. CBLmut was not detected in polycythemia vera, primary myelofibrosis, essential thrombocythemia, or refractory anemia with ring sideroblasts and marked thrombocytosis. CBLmut were underrepresented in JAK2V617F mutated as compared to JAK2V617wt cases (P<0.001), and mutually exclusive of JAK2exon12mut and MPLW515mut. CBLmut were associated with monosomy 7 (P=0.008) and TET2mut (P=0.003). In chronic myelomonocytic leukemia, CBLmut had no significant impact on survival outcomes. Therefore, CBLmut are frequent in chronic myelomonocytic leukemia, absent in classical myeloproliferative neoplasms, and are only exceptionally found in coincidence with JAK-STAT pathway activating mutations. 
700 1 |a Reiter, Andreas  |d 1964-  |e VerfasserIn  |0 (DE-588)172629551  |0 (DE-627)697563766  |0 (DE-576)133488594  |4 aut 
773 0 8 |i Enthalten in  |t Haematologica, the hematology journal  |d Pavia : Ferrata Storti Foundation, 2005  |g 97(2012), 12, Seite 1890-1894  |h Online-Ressource  |w (DE-627)48524375X  |w (DE-600)2186022-1  |w (DE-576)414771095  |x 1592-8721  |7 nnas  |a Use of CBL exon 8 and 9 mutations in diagnosis of myeloproliferative neoplasms and myelodysplastic/myeloproliferative disorders an analysis of 636 cases 
773 1 8 |g volume:97  |g year:2012  |g number:12  |g pages:1890-1894  |g extent:5  |a Use of CBL exon 8 and 9 mutations in diagnosis of myeloproliferative neoplasms and myelodysplastic/myeloproliferative disorders an analysis of 636 cases 
856 4 0 |u http://dx.doi.org/10.3324/haematol.2012.065375  |x Verlag  |x Resolving-System  |3 Volltext 
856 4 0 |u http://www.haematologica.org/content/97/12/1890  |x Verlag  |3 Volltext 
951 |a AR 
992 |a 20180919 
993 |a Article 
994 |a 2012 
998 |g 172629551  |a Reiter, Andreas  |m 172629551:Reiter, Andreas  |d 60000  |d 61200  |e 60000PR172629551  |e 61200PR172629551  |k 0/60000/  |k 1/60000/61200/  |p 4 
999 |a KXP-PPN1581112297  |e 3025850248 
BIB |a Y 
SER |a journal 
JSO |a {"titleAlt":[{"title":"Use of CBL exon eight and nine mutations in diagnosis of myeloproliferative neoplasms and myelodysplastic/myeloproliferative disorders"}],"person":[{"role":"aut","display":"Schnittger, Susanne","family":"Schnittger","given":"Susanne"},{"given":"Andreas","role":"aut","family":"Reiter","display":"Reiter, Andreas"}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"recId":"1581112297","relHost":[{"recId":"48524375X","type":{"media":"Online-Ressource","bibl":"periodical"},"pubHistory":["90.2005 - 98.2013"],"disp":"Use of CBL exon 8 and 9 mutations in diagnosis of myeloproliferative neoplasms and myelodysplastic/myeloproliferative disorders an analysis of 636 casesHaematologica, the hematology journal","part":{"volume":"97","pages":"1890-1894","text":"97(2012), 12, Seite 1890-1894","extent":"5","year":"2012","issue":"12"},"id":{"zdb":["2186022-1"],"eki":["48524375X"],"issn":["1592-8721"]},"origin":[{"dateIssuedKey":"2005","dateIssuedDisp":"2005-2013","publisherPlace":"Pavia","publisher":"Ferrata Storti Foundation"}],"note":["Gesehen am 27.09.2018"],"language":["eng"],"title":[{"title_sort":"Haematologica, the hematology journal","title":"Haematologica, the hematology journal","subtitle":"official organ of the European Hematology Association"}],"physDesc":[{"extent":"Online-Ressource"}]}],"origin":[{"dateIssuedKey":"2012","dateIssuedDisp":"2012-12-01"}],"id":{"eki":["1581112297"],"doi":["10.3324/haematol.2012.065375"]},"note":["Gesehen am 19.09.2018"],"name":{"displayForm":["by Susanne Schnittger, Ulrike Bacher, Tamara Alpermann, Andreas Reiter, Madlen Ulke, Frank Dicker, Christiane Eder, Alexander Kohlmann, Vera Grossmann, Andreas Kowarsch, Wolfgang Kern, Claudia Haferlach, and Torsten Haferlach"]},"physDesc":[{"extent":"5 S."}],"title":[{"title":"Use of CBL exon 8 and 9 mutations in diagnosis of myeloproliferative neoplasms and myelodysplastic/myeloproliferative disorders","subtitle":"an analysis of 636 cases","title_sort":"Use of CBL exon 8 and 9 mutations in diagnosis of myeloproliferative neoplasms and myelodysplastic/myeloproliferative disorders"}],"language":["eng"]} 
SRT |a SCHNITTGERUSEOFCBLEX2012